Devendra Arora1, R M Gupta2, S P S Kochar3. 1. Senior Advisor (Obst & Gyn), Specialist in Maternal Fetal Medicine, Base Hospital, Delhi Cantt 110010, India. 2. Consultant (Pathology & Microbiology), Command Hospital (Northern Command), C/O 56 APO, India. 3. Consultant (Obst & Gyn & Gyn Oncology), Base Hospital, Delhi Cantt-110010, India.
Abstract
BACKGROUND: Prevention of parent to child transmission (PPTCT) program was initiated in Armed Forces to reduce the vertical transmission of HIV by instituting single dose Nevirapine (sdNVP) in untreated HIV positive mothers in labour. The aim of this study was to evaluate the role of sdNVP to decrease viral load of HIV infected mother during labour and its efficacy in prevention of mother to child transmission of HIV. METHODS: Thirty antenatal women tested positive for HIV at our PPTCT centre and delivered between Jan 2006 and May 2008 were evaluated. During labour these women were given sdNVP. Newborns were given syrup Nevirapine. The babies were tested for HIV infection at 48 h and six weeks after delivery. RESULTS: Thirty HIV positive women delivered at our centre and four newborns were found positive for HIV infection at 48 h. After six weeks interval three neonates were detected for HIV infection as one infant at six weeks was found to be negative for HIV infection. CONCLUSION: The protection rate of Nevirapine in untreated HIV positive women is not ideal. It is recommended that all HIV positive women should be offered Highly Active Antiretroviral therapy as primary mode for PPTCT.
BACKGROUND: Prevention of parent to child transmission (PPTCT) program was initiated in Armed Forces to reduce the vertical transmission of HIV by instituting single dose Nevirapine (sdNVP) in untreated HIV positive mothers in labour. The aim of this study was to evaluate the role of sdNVP to decrease viral load of HIV infected mother during labour and its efficacy in prevention of mother to child transmission of HIV. METHODS: Thirty antenatal women tested positive for HIV at our PPTCT centre and delivered between Jan 2006 and May 2008 were evaluated. During labour these women were given sdNVP. Newborns were given syrup Nevirapine. The babies were tested for HIV infection at 48 h and six weeks after delivery. RESULTS: Thirty HIV positive women delivered at our centre and four newborns were found positive for HIV infection at 48 h. After six weeks interval three neonates were detected for HIV infection as one infant at six weeks was found to be negative for HIV infection. CONCLUSION: The protection rate of Nevirapine in untreated HIV positive women is not ideal. It is recommended that all HIV positive women should be offered Highly Active Antiretroviral therapy as primary mode for PPTCT.
Authors: Michelle McConnell; Paul Bakaki; Chineta Eure; Michael Mubiru; Danstan Bagenda; Robert Downing; Flavia Matovu; Michael C Thigpen; Alan E Greenberg; Mary Glenn Fowler Journal: J Acquir Immune Defic Syndr Date: 2007-11-01 Impact factor: 3.731
Authors: Ahidjo Ayouba; Gilbert Tene; Patrick Cunin; Yacouba Foupouapouognigni; Elisabeth Menu; Anfumbom Kfutwah; Jocelyn Thonnon; Gabriella Scarlatti; Marcel Monny-Lobé; Nicole Eteki; Charles Kouanfack; Michèle Tardy; Robert Leke; Maurice Nkam; Anne E Nlend; Françoise Barré-Sinoussi; Paul M V Martin; Eric Nerrienet Journal: J Acquir Immune Defic Syndr Date: 2003-11-01 Impact factor: 3.731
Authors: Anna Coutsoudis; Francois Dabis; Wafaie Fawzi; Philippe Gaillard; Geert Haverkamp; D Robert Harris; J Brooks Jackson; Valerie Leroy; Nicolas Meda; Philippe Msellati; Marie-Louise Newell; Ruth Nsuati; Jennifer S Read; Stefan Wiktor Journal: J Infect Dis Date: 2004-05-26 Impact factor: 5.226
Authors: Jeffrey S A Stringer; Moses Sinkala; Robert L Goldenberg; Rosemary Kumwenda; Edward P Acosta; Grace M Aldrovandi; Julia P Stout; Sten H Vermund Journal: AIDS Date: 2004-04-09 Impact factor: 4.177